MEDIUM confidence: 100% data completeness, but the composite (61) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $72 avg across 3 analysts.
Buy-rated share 76% → 80% over ~3 months (+4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $0.41 | $0.39 | -5.4% |
| Apr 2026 | $2.08 | $2.33 | +12.0% |
| Feb 2026 | $0.76 | $0.90 | +18.4% |
| Oct 2025 | $0.36 | $0.52 | +43.8% |
| Jul 2025 | $0.42 | $0.45 | +7.3% |
| Apr 2025 | $1.03 | $1.18 | +14.6% |
| Feb 2025 | $0.53 | $0.69 | +29.7% |
| Oct 2024 | $0.08 | $0.12 | +58.4% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6.8B— | $12.1B+77.5% | $5.1B-58.2% | $5.2B+3.0% | $9.1B+73.7% |
| EPS (dil.) | $-3.57— | $4.38n/m | $4.20-4.1% | $0.41-90.2% | $3.31+707.3% |
| Free Cash Flow | $607M— | $2.1B+240.0% | $1.2B-43.8% | $573M-50.6% | $2.8B+395.0% |
| Gross Margin | 43.8% | 66.4%+22.6pp | 18.6%-47.8pp | 14.7%-3.9pp | 48.9%+34.2pp |
| Operating Margin | -19.9% | 22.4%+42.3pp | 45.6%+23.3pp | 13.1%-32.5pp | 34.7%+21.6pp |
| Net Margin | -16.7% | 14.6%+31.3pp | 34.2%+19.6pp | 4.4%-29.8pp | 22.5%+18.1pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$9.8M over 180 days (0 open-market buys, 9 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.0%/yr (revenue basis).
Base free cash flow $1.5B (avg FY2023–FY2025; latest year $2.8B) · equity value $33.6B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 61 for EQT Corporation suggests the stock exhibits a mix of strengths and weaknesses. The stock scores high on growth, driven by impressive revenue and earnings growth rates of 73.7% and 640.0%, respectively. However, it trades at a relatively moderate valuation, with a P/E of 11.8, and exhibits weak momentum, with a 12-month return of only 5.0% and a recent 3-month decline of 3.8%. The long-term score is 8 points higher than the short-term score, indicating a slightly more favorable outlook over the longer term.